StockWatch: Avadel Sparks Bidding War; Agios Plummets 51% on Phase III Data
More than two weeks after Pfizer (NYSE: PFE) and Novo Nordisk (NASDAQ Copenhagen: NOVO-B) slugged it out for Metsera (NASDAQ: MTSR), biopharma found itself in the grip of another bidding war.
This latest corporate clash...
CRISPR-edited fungus boosts protein production and cuts environmental impact
In a new study publishing November 19 in the Cell Press journal Trends in Biotechnology, researchers used a gene-editing technology called CRISPR to increase a fungus's production efficiency and cut its production-related environmental impact...
Role of Extracellular Phosphorylation at Synapses Informs Pain Research
Researchers headed by a team at the University of Texas at Dallas’ Center for Advanced Pain Studies (CAPS) have made a fundamental discovery about a key mechanism that enables nervous system connections to strengthen.
The discovery, based...
Senate and House Introduce Bill to Boost U.S. Biotech Manufacturing Infrastructure, Innovation
A bipartisan group of senators and representatives introduced legislation to establish a National Biopharmaceutical Manufacturing Center of Excellence (COE), inspired by recommendations from the National Security Commission on Emerging Biotechnology (NSCEB) April 2025 Action Plan...
Purdue Joins Biomanufacturing Program Designed for Students and Industry Professionals
Major Indiana life science players agreed to elevate the state’s biomanufacturing workforce at the annual BioCrossroads Life Sciences Summit. Leaders from BioCrossroads, Purdue University, Ivy Tech Community College, Eli Lilly, and the Advanced Research...
UNC Greensboro professor receives $3.7 million to advance research on controlling sand flies
Professor Gideon Wasserberg at UNC Greensboro has been awarded a prestigious $3.7 million National Institutes of Health R01 grant to advance his research on controlling sand flies, the vectors of the parasitic disease leishmaniasis.
Leishmaniasis...
New funding advances AI-powered technology to track therapeutic and diseased cells
Targeting and treating diseases first requires being able to find specific cells-which is challenging because they travel within the body and can "hide."
Now, a new round of funding will support advancing technology invented at...
Merck to Acquire Cidara for $9.2B, Bolstering Antiviral Pipeline
Merck & Co. has agreed to acquire Cidara Therapeutics for approximately $9.2 billion, the companies said, in a deal designed to bolster the buyer’s antiviral pipeline with a Phase III drug designed to prevent...
New technique revolutionizes the design of drugs that target ion channels
An international team involving the Institute of Chemical Research, a joint centre of the University of Seville and the Spanish National Research Council, has developed a new technique that will accelerate the design of...
Magnetically Guided Microrobots Deliver Drugs with Pinpoint Accuracy
Researchers headed by a team at ETH Zurich have developed a magnetically guided microrobotics system that they say can navigate the body’s intricate passageways and vasculature to deliver drugs with pinpoint accuracy. Headed by...
